Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity RevMed is seeking an experienced, collaborative Senior Director, Global SOX to lead and scale the Company’s Sarbanes-Oxley compliance and internal controls program. This role has enterprise-wide governance responsibility for ICFR, ITGCs, ITACs, automated controls, key reports, and controls supporting evolving business processes, systems, commercial readiness, and global expansion. As a key Controllership leader, this role partners with functions, auditors, and process owners across the United States, Europe, Japan, Canada, and other markets. The leader will establish global SOX governance and practical regional execution, ensuring rigorous compliance while building risk-based, scalable controls that work effectively with business operations. This role reports to the VP, Finance, Controller, is based at RevMed’s Redwood City headquarters, and works closely with regional Finance, IT, and business teams.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior